MicroPort® Orthopedics launches A Phase II Multicenter Study on Minimally Invasive Hip Arthroplasty of Joint Surgery in Yunnan Province

Suzhou, China, November 27, 2020 — On November 7, 2020, the kick-off meeting for a phase II multicenter study on minimally invasive hip arthroplasty of joint surgery, named SuperPath®, was held in Renshoutang Education & Training Center of MicroPort® Orthopedics China Headquarters, located in Suzhou Industrial Park.

The surgical techniques related to SuperPATH®, the methodology for multicenter studies, as well as the results of the Phase 1 multicenter study were presented by Xu Yongqing, Director of Orthopedics Center of No. 920 Hospital of PLA Joint Logistics Support Force. Dr. Li Chuan, President of the Orthopedics Hospital at No. 920 Hospital of the PLA and Dr. Xing Dan from Peking University People’s Hospital. The overall planning for the Phase II multicenter study was presented to the presidents and key professors from 30 hospitals in attendance at the meeting.

In the opening speech, President Xu Yongqing commented that, “MicroPort® Orthopedics had engaged in remarkable cooperation with hospitals during the phase I multicenter study on hip arthroplasty, leading to experts’ recognition of SuperPATH®.”

President Xu Yongqing introduced the development, surgical techniques and clinical application of SuperPATH®, as well as the experience of more than 100 SuperPATH® operations at No. 920 Hospital of the PLA. He emphasized four critical points to be noted during an operation – accurate preoperative planning with details, anteversion and intraoperative fluoroscopy, the cleaning of the lateral glenoid labrum of acetabulum, and the creation of percutaneous access close to the posterior femoral edge without damaging the sciatic nerve. Furthermore, he also shared cases with attendees, where all the patients had been able to get out of the bed within 4 hours after the operation, showing good recovery, such as doing hip movements on their own soon after the operation.

Moreover, at the meeting, Dr. Li Chuan shared with the attendees the surgical videos of Professor Jimmy Chow (the inventor of SuperPATH®) and himself, as well as the surgical techniques and matters noted through detailed elaboration on surgical cases. Dr. Li Chuan also introduced the results of the Phase I multicenter study on minimally invasive hip arthroplasty and the overall planning for the Phase II multicenter study planned. Dr. Xing Dan shared detailed research techniques, introduced the objectives and methods of the multicenter clinical study design and suggested that attention should be paid to collecting information on the patients and the surgeon’s operation, as well as sample size estimation.

About MicroPort® Orthopedics China

The MicroPort® Orthopedics China Headquarters, located in Suzhou, is an orthopedic innovation industrial park characterized by integrated R&D, manufacturing, logistics and academic functions. Renshoutang Education & Training Center, one part of the site opened in July 2019, providing a hardware and software platform for MicroPort® Orthopedics to communicate and cooperate with colleges and universities, scientific research institutions, doctors and experts. As one of the rare large-scale, modern medical device application training centers in China, this Center covers an area of 8,000 square meters and is equipped with cutting-edge medical training equipment, helping further improve the skills of clinical medical professionals and enhancing the safety of orthopedic implant surgery. MicroPort® Orthopedics inherits and passes down the innovative gene of the Group and will continuously strive to achieve the goals of production-education-research cooperation, R&D innovation and intelligent manufacturing to provide even more effective, integrated solutions to the orthopedic diseases.